Focusing on Quality of Life Improvement: Integrating Digital Health Platforms in the Global Canine Dilated Cardiomyopathy Drugs Market
The global canine dilated cardiomyopathy drugs market is experiencing notable growth, reaching an estimated value of US$ 3643.6 million in 2023. Following this positive start, the market is projected to grow steadily at a Compound Annual Growth Rate (CAGR) of 4.80%, potentially generating revenues worth over US$ 5822.9 million by 2033. This remarkable progress highlights the...
0 Comentários
0 Compartilhamentos